Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
|---|---|---|---|---|---|---|---|---|---|
Patent 11040040 was granted and assigned to Corvus Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office. | 11040040 | June 22, 2021 | |||||||
Patent 10912776 was granted and assigned to Corvus Pharmaceuticals on February, 2021 by the United States Patent and Trademark Office. | 10912776 | February 9, 2021 | |||||||
Patent 11266649 was granted and assigned to Corvus Pharmaceuticals on March, 2022 by the United States Patent and Trademark Office. | 11266649 | March 8, 2022 | |||||||
Patent 11254686 was granted and assigned to Corvus Pharmaceuticals on February, 2022 by the United States Patent and Trademark Office. | 11254686 | February 22, 2022 | |||||||
Patent 11008314 was granted and assigned to Corvus Pharmaceuticals on May, 2021 by the United States Patent and Trademark Office. | 11008314 | May 18, 2021 | |||||||
10870652 | December 22, 2020 | ||||||||
10654825 | May 19, 2020 | ||||||||
Patent 10793636 was granted and assigned to Corvus Pharmaceuticals on October, 2020 by the United States Patent and Trademark Office. | 10793636 | October 6, 2020 | |||||||
Patent 12116635 was granted and assigned to Corvus Pharmaceuticals on October, 2024 by the United States Patent and Trademark Office. | 12116635 | October 15, 2024 | |||||||
Patent 12023337 was granted and assigned to Corvus Pharmaceuticals on July, 2024 by the United States Patent and Trademark Office. | 12023337 | July 2, 2024 |